CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Washington University School of Medicine
Jazz Pharmaceuticals
Seagen Inc.
AstraZeneca
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Institut Paoli-Calmettes
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NKGen Biotech, Inc.
Washington University School of Medicine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Western Regional Medical Center
Merrimack Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)